The Covid-19 vaccine, developed by AstraZeneca and Oxford University, could be used as an effective booster against the coronavirus, the Financial Times reported Wednesday, citing people familiar with the unpublished study. of Oxford University.
The concern among scientists was that the adenoviral vector, which is the mechanism of delivery of the vaccine, may become unrecognizable to the human body after repeated use, according to the financial publication, but added that the study proves otherwise.
“The study kills all these arguments that you can’t use adenoviruses more than once,” the Financial Times reported, citing one of its sources.
Another source claims that the immune response provoked by the booster (additional) injection “may be enough to deal with almost any variant of the coronavirus”.
– .
